{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:13:07Z","timestamp":1778904787008,"version":"3.51.4"},"reference-count":32,"publisher":"Japan Neurosurgical Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2026,5,15]]},"DOI":"10.2176\/jns-nmc.2025-0366","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:08:39Z","timestamp":1773266919000},"page":"274-283","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Impact of Calcification, Corpus Callosum Invasion, and CDKN2A\/B Hemizygous Deletion in Oligodendroglioma: A Single-center Retrospective Study"],"prefix":"10.2176","volume":"66","author":[{"given":"Takuma","family":"SUMI","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"UZUKA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"KANO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"SHIBAO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadzki","family":"MATSUDA","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumi","family":"HIGUCHI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Teikyo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"AKUTSU","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Ostrom QT, Gittleman H, Truitt G, et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol. 2018;20 (suppl 4):iv1-iv86. doi: 10.1093\/neuonc\/noy131","DOI":"10.1093\/neuonc\/noy131"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2) Brat DJ, Aldape K, Colman H, et al. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol. 2020;139 (3):603-8. doi: 10.1007\/s00401-020-02127-9","DOI":"10.1007\/s00401-020-02127-9"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Lebrun C, Fontaine D, Ramaioli A, et al. Long-term outcome of oligodendrogliomas. Neurology. 2004;62 (10):1783-7. doi: 10.1212\/01.WNL.0000125196.88449.89","DOI":"10.1212\/01.WNL.0000125196.88449.89"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Price M, Ballard C, Benedetti J, et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021. Neuro Oncol. 2024;26 (suppl 6):vi1-vi85. doi: 10.1093\/neuonc\/noae145","DOI":"10.1093\/neuonc\/noae145"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5) Cancer Genome Atlas Research Network, Brat DJ, Verhaak RGW, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372 (26):2481-98. doi: 10.1056\/NEJMoa1402121","DOI":"10.1056\/NEJMoa1402121"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6) Eckel-Passow JE, Lachance DH, Molinaro AM, et al. Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372 (26):2499-508. doi: 10.1056\/NEJMoa1407279","DOI":"10.1056\/NEJMoa1407279"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Halani SH, Yousefi S, Velazquez Vega J, et al. Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways. NPJ Precis Oncol. 2018;2:24. doi: 10.1038\/s41698-018-0067-9","DOI":"10.1038\/s41698-018-0067-9"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8) Zadeh G, Khan OH, Vogelbaum M, et al. Much debated controversies of diffuse low-grade gliomas. Neuro Oncol. 2015;17 (3):323-6. doi: 10.1093\/neuonc\/nou368","DOI":"10.1093\/neuonc\/nou368"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9) Mohile NA, Messersmith H, Gatson NT, et al. Therapy for diffuse astrocytic and oligodendroglial tumors in adults: ASCO-SNO guideline. J Clin Oncol. 2022;40 (4):403-26. doi: 10.1200\/JCO.21.02036","DOI":"10.1200\/JCO.21.02036"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10) Weller M, van den Bent M, Preusser M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2021;18 (3):170-86. doi: 10.1038\/s41571-020-00447-z","DOI":"10.1038\/s41571-020-00447-z"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11) Simonetti G, Gaviani P, Botturi A, et al. Clinical management of grade III oligodendroglioma. Cancer Manag Res. 2015;7:213-23. doi: 10.2147\/CMAR.S56975","DOI":"10.2147\/CMAR.S56975"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) El-Hateer H, Souhami L, Roberge D, et al. Low-grade oligodendroglioma: an indolent but incurable disease? Clinical article. J Neurosurg. 2009;111 (2):265-71. doi: 10.3171\/2008.11.JNS08983","DOI":"10.3171\/2008.11.JNS08983"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Dehghani F, Schachenmayr W, Laun A, et al. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases. Acta Neuropathol. 1998;95 (5):493-504. doi: 10.1007\/s004010050830","DOI":"10.1007\/s004010050830"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14) Nakasu S, Deguchi S, Nakasu Y. Frequency and prognostic impact of <i>CDKN2A\/B<\/i> alteration in oligodendrogliomas: systematic review and meta-analysis. Neurol Med Chir (Tokyo). 2024;64 (12):442-50. doi: 10.2176\/jns-nmc.2024-0105","DOI":"10.2176\/jns-nmc.2024-0105"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Li M, Ren X, Chen X, et al. Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p\/19q non-codeleted lower-grade glioma. Eur Radiol. 2022;32 (6):3869-79. doi: 10.1007\/s00330-021-08500-w","DOI":"10.1007\/s00330-021-08500-w"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) Patel SH, Poisson LM, Brat DJ, et al. T2-FLAIR mismatch, an imaging biomarker for IDH and 1p\/19q status in lower-grade gliomas: a TCGA\/TCIA project. Clin Cancer Res. 2017;23 (20):6078-85. doi: 10.1158\/1078-0432.CCR-17-0560","DOI":"10.1158\/1078-0432.CCR-17-0560"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17) Zhao K, Sun G, Wang Q, et al. The diagnostic value of conventional MRI and CT features in the identification of the IDH1-mutant and 1p\/19q co-deletion in WHO grade II gliomas. Acad Radiol. 2021;28 (7):e189-98. doi: 10.1016\/j.acra.2020.03.008","DOI":"10.1016\/j.acra.2020.03.008"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18) Saito T, Muragaki Y, Maruyama T, et al. Calcification on CT is a simple and valuable preoperative indicator of 1p\/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas. Brain Tumor Pathol. 2016;33 (3):175-82. doi: 10.1007\/s10014-016-0249-5","DOI":"10.1007\/s10014-016-0249-5"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19) van Lent DI, van Baarsen KM, Snijders TJ, et al. Radiological differences between subtypes of WHO 2016 grade II-III gliomas: a systematic review and meta-analysis. Neurooncol Adv. 2020;2 (1):vdaa044. doi: 10.1093\/noajnl\/vdaa044","DOI":"10.1093\/noajnl\/vdaa044"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20) Mickevicius NJ, Carle AB, Bluemel T, et al. Location of brain tumor intersecting white matter tracts predicts patient prognosis. J Neurooncol. 2015;125 (2):393-400. doi: 10.1007\/s11060-015-1928-5","DOI":"10.1007\/s11060-015-1928-5"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21) Hazaymeh M, L\u00f6ber-Handwerker R, D\u00f6ring K, et al. Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration. Sci Rep. 2022;12 (1):19208. doi: 10.1038\/s41598-022-23794-6","DOI":"10.1038\/s41598-022-23794-6"},{"key":"22","unstructured":"22) Go JL, Zee CS. Unique CT imaging advantages. Hemorrhage and calcification. Neuroimaging Clin N Am. 1998;8 (3):541-58."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Otani R, Uzuka T, Higuchi F, et al. IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis. Cancer Sci. 2018;109 (7):2327-35. doi: 10.1111\/cas.13635","DOI":"10.1111\/cas.13635"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24) Umehara T, Arita H, Yoshioka E, et al. Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts. Acta Neuropathol Commun. 2019;7 (1):99. doi: 10.1186\/s40478-019-0749-8","DOI":"10.1186\/s40478-019-0749-8"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25) Zhu Q, Jiang H, Cui Y, et al. Intratumoral calcification: not only a diagnostic but also a prognostic indicator in oligodendrogliomas. Eur Radiol. 2024;34 (6):3674-85. doi: 10.1007\/s00330-023-10405-9","DOI":"10.1007\/s00330-023-10405-9"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26) Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002;20 (8):2076-84. doi: 10.1200\/JCO.2002.08.121","DOI":"10.1200\/JCO.2002.08.121"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27) Kocakavuk E, Johnson KC, Sabedot TS, et al. Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas. Neuro Oncol. 2023;25 (9):1721-3. doi: 10.1093\/neuonc\/noad095","DOI":"10.1093\/neuonc\/noad095"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28) van der Vaart T, Wijnenga MMJ, van Garderen KA, et al. Differences in the prognostic role of age, extent of resection, and tumor grade between astrocytoma IDHmt and oligodendroglioma: a single-center cohort study. Clin Cancer Res. 2024;30 (17):3837-44. doi: 10.1158\/1078-0432.CCR-24-0901","DOI":"10.1158\/1078-0432.CCR-24-0901"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29) Fisher BJ, Naumova E, Leighton CC, et al. Ki-67: a prognostic factor for low-grade glioma? Int J Radiat Oncol Biol Phys. 2002;52 (4):996-1001. doi: 10.1016\/S0360-3016(01)02720-1","DOI":"10.1016\/S0360-3016(01)02720-1"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30) Kinslow CJ, Garton ALA, Rae AI, et al. Extent of resection and survival for oligodendroglioma: a U.S. population-based study. J Neurooncol. 2019;144 (3):591-601. doi: 10.1007\/s11060-019-03261-5","DOI":"10.1007\/s11060-019-03261-5"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31) Bush NAO, Young JS, Zhang Y, et al. A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma. J Neurooncol. 2021;153 (3):447-54. doi: 10.1007\/s11060-021-03781-z","DOI":"10.1007\/s11060-021-03781-z"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32) Kano H, Niranjan A, Khan A, et al. Does radiosurgery have a role in the management of oligodendrogliomas? J Neurosurg. 2009;110 (3):564-71. doi: 10.3171\/2008.5.17582","DOI":"10.3171\/2008.5.17582"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/66\/5\/66_2025-0366\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:27:24Z","timestamp":1778902044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/66\/5\/66_2025-0366\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2025-0366","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"2025-0366"}}